FTO inhibitor FB23-2 and iron death inducer erastin could effectively enhance radiosensitivity, and therefore, these modulators could be potential targets for antagonizing the radioresistance of NPC. This evidence concerns the gene FTO and nasopharyngeal carcinoma.